About Defy VC
Defy VC, also known as Defy Partners, is a Silicon Valley early-stage venture capital firm founded by experienced operator-investors, with a thesis focused on backing founder-operators building category-defining companies at seed and Series A. The firm has an active website, LinkedIn, Twitter, and Crunchbase presence, and has historically invested across enterprise software, consumer, fintech, and selective healthcare technology, with healthcare exposure that includes digital health and healthcare workflow software rather than therapeutics or devices. Check sizes typically range from $1M to $5M at seed and Series A, with the firm capable of leading rounds and bringing meaningful operator-network value. For healthcare AI founders, Defy is a credible potential lead if you are building software-style healthcare AI with strong founder-operator credentials, capital-efficient unit economics, and a clear path to commercial scale through enterprise or provider sales. The strongest fit is for founders with prior operating experience at well-known technology companies who are building applied AI for healthcare workflows, revenue cycle, clinical decision support, or adjacent enterprise healthcare problems. Founders building biotech, regulated diagnostics, capital-intensive devices, or care delivery models requiring payer contracting and risk-bearing will likely find Defy a non-fit. The firm’s value-add is most credible around go-to-market discipline, founder coaching, and connecting to the broader Silicon Valley operator and capital network. Entry path is warm referral from a portfolio CEO, LinkedIn outreach to the partners, or Twitter engagement. Founders should come ready to discuss founder background, market category framing, and a sharp narrative about why now and why this team.
Founder reviews
Pitch / review this investor
Have you raised from Defy VC? Founders only — share your honest experience (anonymous OK, moderated before publishing).